Effect of FTY720 on the SET-PP2A complex in acute myeloid leukemia; SET binding drugs have antagonistic activity

被引：59

作者：

Pippa, R. ^{[1
]}

Dominguez, A. ^{[1
]}

Christensen, D. J. ^{[2
]}

Moreno-Miralles, I. ^{[1
]}

Blanco-Prieto, M. J. ^{[3
]}

Vitek, M. P. ^{[2
]}

Odero, M. D. ^{[1
,4
]}

机构：

[1] Univ Navarra, Ctr Appl Med Res CIMA, Hematol Oncol Program, Navarra, Spain

[2] Oncotide Pharmaceut, Res Triangle Pk, NC USA

[3] Univ Navarra, Sch Pharm, Dept Pharm & Pharmaceut Technol, Navarra, Spain

[4] Univ Navarra, Dept Biochem & Genet, Navarra, Spain

来源：

LEUKEMIA | 2014年 / 28卷 / 09期

关键词：

PROTEIN PHOSPHATASE 2A; INHIBITION; I-2(PP2A)/SET; ACTIVATION; EFFICACY; THERAPY; EVENT;

D O I：

10.1038/leu.2014.141

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1915 / 1918

页数：4

共 15 条

[1] Antagonism of SET Using OP449 Enhances the Efficacy of Tyrosine Kinase Inhibitors and Overcomes Drug Resistance in Myeloid Leukemia [J].

Agarwal, Anupriya ;

MacKenzie, Ryan J. ;

Pippa, Raffaella ;

Eide, Christopher A. ;

Oddo, Jessica ;

Tyner, Jeffrey W. ;

Sears, Rosalie ;

Vitek, Michael P. ;

Odero, Maria D. ;

Christensen, Dale J. ;

Druker, Brian J. .

CLINICAL CANCER RESEARCH, 2014, 20 (08) :2092-2103

[2] Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I2PP2A/SET [J].

Arnaud, Lisette ;

Chen, She ;

Liu, Fei ;

Li, Bin ;

Khatoon, Sabiha ;

Grundke-Iqbal, Inge ;

Iqbal, Khalid .

FEBS LETTERS, 2011, 585 (17) :2653-2659

[3] Apolipoprotein E and Peptide Mimetics Modulate Inflammation by Binding the SET Protein and Activating Protein Phosphatase 2A [J].

Christensen, Dale J. ;

Ohkubo, Nobutaka ;

Oddo, Jessica ;

Van Kanegan, Michael J. ;

Neil, Jessica ;

Li, Fengqiao ;

Colton, Carol A. ;

Vitek, Michael P. .

JOURNAL OF IMMUNOLOGY, 2011, 186 (04) :2535-2542

[4] PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect [J].

Cristobal, I. ;

Garcia-Orti, L. ;

Cirauqui, C. ;

Alonso, M. M. ;

Calasanz, M. J. ;

Odero, M. D. .

LEUKEMIA, 2011, 25 (04) :606-614

[5] Overexpression of SET is a recurrent event associated with poor outcome and contributes to protein phosphatase 2A inhibition in acute myeloid leukemia [J].

Cristobal, Ion ;

Garcia-Orti, Laura ;

Cirauqui, Cristina ;

Cortes-Lavaud, Xabier ;

Garcia-Sanchez, Maria A. ;

Calasanz, Maria J. ;

Odero, Maria D. .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (04) :543-550

[6]

Estella Hermoso-de Mendoza A, 2014, J BIOMED NA IN PRESS

[7] FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia [J].

Neviani, Paolo ;

Santhanam, Ramasamy ;

Oaks, Joshua J. ;

Eiring, Anna M. ;

Notari, Mario ;

Blaser, Bradley W. ;

Liu, Shujun ;

Trotta, Rossana ;

Muthusamy, Natarajan ;

Gambacorti-Passerini, Carlo ;

Druker, Brian J. ;

Cortes, Jorge ;

Marcucci, Guido ;

Chen, Ching-Shih ;

Verrills, Nicole M. ;

Roy, Denis C. ;

Caligiuri, Michael A. ;

Bloomfield, Clara D. ;

Byrd, John C. ;

Perrotti, Danilo .

JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (09) :2408-2421

[8] PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells [J].

Neviani, Paolo ;

Harb, Jason G. ;

Oaks, Joshua J. ;

Santhanam, Ramasamy ;

Walker, Christopher J. ;

Ellis, Justin J. ;

Ferenchak, Gregory ;

Dorrance, Adrienne M. ;

Paisie, Carolyn A. ;

Eiring, Anna M. ;

Ma, Yihui ;

Mao, Hsiaoyin C. ;

Zhang, Bin ;

Wunderlich, Mark ;

May, Philippa C. ;

Sun, Chaode ;

Saddoughi, Sahar A. ;

Bielawski, Jacek ;

Blum, William ;

Klisovic, Rebecca B. ;

Solt, Janelle A. ;

Byrd, John C. ;

Volinia, Stefano ;

Cortes, Jorge ;

Huettner, Claudia S. ;

Koschmieder, Steffen ;

Holyoake, Tessa L. ;

Devine, Steven ;

Caligiuri, Michael A. ;

Croce, Carlo M. ;

Garzon, Ramiro ;

Ogretmen, Besim ;

Arlinghaus, Ralph B. ;

Chen, Ching-Shih ;

Bittman, Robert ;

Hokland, Peter ;

Roy, Denis-Claude ;

Milojkovic, Dragana ;

Apperley, Jane ;

Goldman, John M. ;

Reid, Alistair ;

Mulloy, James C. ;

Bhatia, Ravi ;

Marcucci, Guido ;

Perrotti, Danilo .

JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (10) :4144-4157

[9] Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies [J].

Oaks, Joshua J. ;

Santhanam, Ramasamy ;

Walker, Christopher J. ;

Roof, Steve ;

Harb, Jason G. ;

Ferenchak, Greg ;

Eisfeld, Ann-Kathrin ;

Van Brocklyn, James R. ;

Briesewitz, Roger ;

Saddoughi, Sahar A. ;

Nagata, Kyosuke ;

Bittman, Robert ;

Caligiuri, Michael A. ;

Abdel-Wahab, Omar ;

Levine, Ross ;

Arlinghaus, Ralph B. ;

Quintas-Cardama, Alfonso ;

Goldman, John M. ;

Apperley, Jane ;

Reid, Alistair ;

Milojkovic, Dragana ;

Ziolo, Mark T. ;

Marcucci, Guido ;

Ogretmen, Besim ;

Neviani, Paolo ;

Perrotti, Danilo .

BLOOD, 2013, 122 (11) :1923-1934

[10] Protein phosphatase 2A: a target for anticancer therapy [J].

Perrotti, Danilo ;

Neviani, Paolo .

LANCET ONCOLOGY, 2013, 14 (06) :E229-E238

← 1 2 →